Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports the completion of a Phase 2 study evaluating Verekitug (UPB-101) for chronic rhinosinusitis with nasal polyps.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Verekitug (UPB-101)

Snippet

Sponsor: Upstream Bio Inc. | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | Status: COMPLETED